Hep C Virus - Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in

Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in
[Press Release] PR Newswire via Yahoo! Finance - Feb 27 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in-class anti-viral compound Tarvacin Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus infected patients.Save to My Web

Waging War on Hepatitis C
RedNova - Feb 21 11:46 AM
Many viruses have figured out ways to elude the body's protective system. One of the cleverest is the hepatitis-C virus. In scores of millions of infected people, the bug does its damage by making trillions of new viruses a day, years after year.Save to My Web

BUSINESS DIGEST
San Jose Mercury News - Feb 24 4:26 PM
Local and StateNews Rambus, a Los Altos designer of high-speed memory chips, won a ruling Thursday requiring Samsung Electronics to turn over documents from a Justice Department price-fixing investigation.Save to My Web

Tampa Firm's Medication Has Enormous Potential As Hepatitis Treatment
The Tampa Tribune - Feb 24 7:50 PM
TAMPA - Digestive disease specialist David Heiman has dozens of chronic hepatitis C patients who do not respond to the drugs now available. Their only hope is a transplant before their liver gives out.Save to My Web

Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2005 Financial Results
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 1:00 PM
Anadys Pharmaceuticals, Inc. , a biopharmaceutical company committed to the discovery, development and commercialization of novel medicines for the treatment of hepatitis, other serious infections, and cancer, today reported its financial results for the fourth quarter and year ended December 31, 2005.Save to My Web